X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-15 | BDX | Goette Roland | EVP, Pres EMEA | S - Sale | $236.74 | -3,300 | 12,493 | -21% | -$781,224 | ||||||
2024-05-13 | BDX | Goette Roland | EVP, Pres EMEA | S - Sale | $236.70 | -3,300 | 15,793 | -17% | -$781,121 | ||||||
2024-04-30 | BDX | Garrison Michael David | EVP, Pres Medical | S - Sale | $232.81 | -1,715 | 5,381 | -24% | -$399,269 | ||||||
2024-03-14 | BDX | Spoerel Thomas J | SVP,Controller, Chief Acct Off | S - Sale | $238.29 | -282 | 2,393 | -11% | -$67,198 | ||||||
2023-12-11 | BDX | Garrison Michael David | EVP, Pres Medical | S - Sale | $232.46 | -1,239 | 7,274 | -15% | -$288,018 | ||||||
2023-11-28 | BDX | Byrd Richard | EVP, Pres Interventional | S - Sale | $238.47 | -2,156 | 4,120 | -34% | -$514,141 | ||||||
2023-09-05 | BDX | Byrd Richard | EVP, Pres Interventional | S - Sale | $274.48 | -459 | 3,444 | -12% | -$125,986 | ||||||
2023-08-28 | BDX | Fraser Claire | Dir | S - Sale | $281.66 | -848 | 21,608 | -4% | -$238,848 | ||||||
D | 2023-08-11 | BDX | Hickey David | EVP, Pres, Life Sciences | S - Sale+OE | $277.85 | -2,974 | 4,199 | -41% | -$826,326 | |||||
2023-08-08 | BDX | Garrison Michael David | EVP, Pres Medical | S - Sale | $277.13 | -1,300 | 5,157 | -20% | -$360,269 | ||||||
2023-02-03 | BDX | Byrd Richard | EVP, Pres Interventional | S - Sale | $248.60 | -1,421 | 4,119 | -26% | -$353,261 | ||||||
2022-08-15 | BDX | Hickey David | EVP, Pres, Life Sciences | S - Sale | $265.00 | -475 | 3,331 | -12% | -$125,875 | ||||||
D | 2022-08-15 | BDX | Polen Thomas E Jr | COB, CEO, Pres | S - Sale+OE | $265.13 | -9,500 | 28,878 | -25% | -$2,518,735 | |||||
DM | 2022-08-09 | BDX | Khichi Samrat S. | EVP, GC | S - Sale+OE | $260.44 | -16,480 | 5,928 | -74% | -$4,292,051 | |||||
D | 2022-08-09 | BDX | Polen Thomas E Jr | EVP | S - Sale+OE | $260.00 | -1,652 | 28,878 | -5% | -$429,520 | |||||
D | 2022-06-07 | BDX | Spoerel Thomas J | VP Controller, Chief Acct Off | S - Sale+OE | $260.00 | -443 | 1,124 | -28% | -$115,180 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |